Condition
Disorder of Sex Development, 46,XY
Total Trials
3
Recruiting
2
Active
2
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
33%
1 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 3 (1)
Trial Status
Recruiting2
Unknown1
Clinical Trials (3)
Showing 3 of 3 trials
NCT05867979Not ApplicableRecruitingPrimary
Search for Structural Variants in Patients With DSD and Inconclusive Molecular Diagnosis
NCT06692049Recruiting
Gonadal Tissue Cryopreservation for Fertility Preservation in Children with a Disorder of Sex Development
NCT04831099Phase 3UnknownPrimary
Testosterone Treatment in a Patient With 17β-hydroxysteroid Dehydrogenase Type 3 Deficiency: an N-of-1 Study
Showing all 3 trials